Publicaciones en las que colabora con MARÍA ANTONIA CAMACHO SÁNCHEZ (20)

2007

  1. Experiencia piloto en tecnología farmacéutica: Análisis de la implementación de una nueva metodología didáctica

    Experiencias de implantación de metodologías ECTS en cursos piloto completos: II Jornadas Nacionales de Metodologías ECTS. Badajoz, 19, 20 y 21 de septiembre de 2007 (Servicio de Publicaciones)

2004

  1. Statistical method for evaluation of dissolution stability in the formulation development of solid dosage forms: Tablets of amonafide

    Pharmazie, Vol. 59, Núm. 7, pp. 541-547

2001

  1. Procedure to evaluate the stability during processing and storage of a medicated premix and medicated farm feed: Erythromycin thiocyanate

    Journal of Agricultural and Food Chemistry, Vol. 49, Núm. 8, pp. 3709-3712

  2. Statistical evaluation for stability studies under stress storage conditions

    Farmaco, Vol. 56, Núm. 11, pp. 877-883

2000

  1. Stability study of a sulfadimidine-containing medicated premix and its mixture with farm feed

    Journal of Agricultural and Food Chemistry, Vol. 48, Núm. 12, pp. 5969-5974

1999

  1. Microbiological bioassay of erythromycin thiocyanate: Optimisation and validation

    Journal of Pharmaceutical and Biomedical Analysis, Vol. 21, Núm. 2, pp. 347-353

1998

  1. High performance liquid chromatographic method for the determination of lobenzarit disodium in a sustained release tablet formulation

    Arzneimittel-Forschung/Drug Research, Vol. 48, Núm. 8, pp. 832-835

1995

  1. Design and formulation of tablets of a new antineoplastic drug: Amonafide

    Drug Development and Industrial Pharmacy, Vol. 21, Núm. 2, pp. 185-197

1994

  1. Pharmaceutical development of tablets of a new antineoplastic drug: mitonafide

    Pharmaceutica Acta Helvetiae, Vol. 69, Núm. 2, pp. 101-105

  2. Photolability evaluation of the new cytostatic drug mitonafide

    Arzneimittel-Forschung/Drug Research, Vol. 44, Núm. 1, pp. 81-83

  3. Qualitative and quantitative determination of two new antitumor agents from 1-8 naphthalimides in tablets. Validation of a high performance liquid chromatography method

    Arzneimittel-Forschung/Drug Research, Vol. 44, Núm. 5, pp. 659-662

  4. Solid state interactions of two new antineoplastic drugs (mitonafide and amonafide) and common tablet excipients in preformulation studies

    European Journal of Pharmaceutics and Biopharmaceutics, Vol. 40, Núm. 1, pp. 41-43

1993

  1. Validation protocol of analytical methods for finished pharmaceutical products

    S.T.P. Pharma Pratiques, Vol. 3, Núm. 3, pp. 197-202

1992

  1. Studies about the oral bioavailability of mitonafide and 2HCl amonafide, two new cytotoxic molecules

    Farmaco, Vol. 47, Núm. 4, pp. 497-508

  2. Validation of two analytical methods applied to two new cytostatic drugs

    S.T.P. Pharma Pratiques, Vol. 2, Núm. 2, pp. 93-99

1991

  1. PREDICCION DE ESTABILIDAD DE AMOXICILINA EN PREPARADOS DE DISPERSION EXTEMPORANEA

    Anales de la Real Academia de Farmacia, Vol. 57, Núm. 4, pp. 553-561

  2. The behaviour under atmospheric humidity of two benzoisoquinoline-diones (mitonafide and 2HCl amonafide)

    Farmaco, Vol. 46, Núm. 9, pp. 1091-1096

1989

  1. Stability of amonafide solutions in front of light and temperature

    Ciencia e Industria Farmaceutica, Vol. 8, Núm. 3-4, pp. 104-109

1988

  1. Diazepam determination and its matebolites in urine samples

    Farmacia Clinica, Vol. 5, Núm. 10, pp. 56-64

1987

  1. Interferencias en la valoración espectrofotométrica de la vitamina B12 en presencia de vitamina C

    El farmacéutico: profesión y cultura, Núm. 38, pp. 35-39